UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (312) 312
humans (309) 309
life sciences & biomedicine (306) 306
hematology (189) 189
middle aged (181) 181
female (180) 180
male (180) 180
adult (168) 168
aged (166) 166
biological and medical sciences (131) 131
medical sciences (121) 121
aged, 80 and over (114) 114
hematologic and hematopoietic diseases (108) 108
oncology (107) 107
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (106) 106
prognosis (99) 99
leukemia, myeloid, acute - genetics (90) 90
chemistry (85) 85
microbiology (84) 84
beer (83) 83
biochemistry (83) 83
compositions or test papers therefor (83) 83
condition-responsive control in microbiological orenzymological processes (83) 83
enzymology (83) 83
measuring or testing processes involving enzymes, nucleicacids or microorganisms (83) 83
metallurgy (83) 83
mutation or genetic engineering (83) 83
processes of preparing such compositions (83) 83
spirits (83) 83
vinegar (83) 83
wine (83) 83
mutation (81) 81
adolescent (75) 75
physics (71) 71
genetics & heredity (61) 61
investigating or analysing materials by determining theirchemical or physical properties (61) 61
measuring (61) 61
testing (61) 61
abridged index medicus (59) 59
karyotyping (54) 54
chromosome aberrations (53) 53
young adult (51) 51
leukemia (49) 49
acute myeloid leukemia (43) 43
cytogenetics (43) 43
in situ hybridization, fluorescence (43) 43
acute disease (42) 42
hemic and lymphatic diseases (36) 36
analysis (35) 35
leukemia, myeloid - genetics (35) 35
translocation, genetic (35) 35
polymerase chain reaction (34) 34
immunophenotyping (32) 32
cohort studies (31) 31
genetic aspects (31) 31
nuclear proteins - genetics (31) 31
leukemia, myeloid, acute - diagnosis (30) 30
survival analysis (29) 29
fms-like tyrosine kinase 3 - genetics (28) 28
leukemia, myeloid, acute - pathology (28) 28
myelodysplastic syndromes - genetics (28) 28
cancer (26) 26
myeloproliferative disorders - genetics (26) 26
leukemia, myeloid, acute - mortality (25) 25
minimal residual disease (25) 25
oncogene proteins, fusion - genetics (25) 25
recurrence (25) 25
tumors (25) 25
dna-binding proteins - genetics (24) 24
gene expression (24) 24
gene expression profiling (24) 24
animals (23) 23
biomarkers, tumor - genetics (23) 23
hematology, oncology and palliative medicine (23) 23
child (22) 22
disease-free survival (22) 22
mutation - genetics (22) 22
reverse transcriptase polymerase chain reaction (22) 22
risk factors (22) 22
follow-up studies (21) 21
research (21) 21
survival rate (21) 21
chromosome banding (19) 19
dna mutational analysis (19) 19
flow cytometry (19) 19
janus kinase 2 - genetics (19) 19
neoplasm proteins - genetics (19) 19
core binding factor alpha 2 subunit - genetics (18) 18
genetic research (18) 18
genes (17) 17
medicine & public health (17) 17
mice (17) 17
multiparameter flow cytometry (17) 17
oligonucleotide array sequence analysis (17) 17
proto-oncogene proteins - genetics (17) 17
remission induction (17) 17
aml (16) 16
cytogenetic analysis (16) 16
flow cytometry - methods (16) 16
imatinib mesylate (16) 16
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 24, pp. 2305 - 2315
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 02/2014, Volume 32, Issue 5, pp. 415 - 423
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Piperazines - administration & dosage | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Young Adult | Benzamides - administration & dosage | Time Factors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Aged, 80 and over | Adult | Female | Benzamides - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Pyrimidines - administration & dosage | Risk Factors | Proportional Hazards Models | Treatment Outcome | Imatinib Mesylate | Piperazines - adverse effects | Remission Induction | Cytarabine - administration & dosage | Disease Progression | Interferon-alpha - administration & dosage | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Fusion Proteins, bcr-abl - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Fusion Proteins, bcr-abl - antagonists & inhibitors | Pyrimidines - adverse effects | Aged | Fusion Proteins, bcr-abl - metabolism | Index Medicus
Journal Article
Nature genetics, ISSN 1061-4036, 01/2013, Volume 45, Issue 1, pp. 18 - 24
Journal Article